DE10196025T1 - Dermatologische Verwendung und ein dermatologisches Präparat - Google Patents

Dermatologische Verwendung und ein dermatologisches Präparat

Info

Publication number
DE10196025T1
DE10196025T1 DE10196025T DE10196025T DE10196025T1 DE 10196025 T1 DE10196025 T1 DE 10196025T1 DE 10196025 T DE10196025 T DE 10196025T DE 10196025 T DE10196025 T DE 10196025T DE 10196025 T1 DE10196025 T1 DE 10196025T1
Authority
DE
Germany
Prior art keywords
dermatological
preparation
dermatological preparation
dermatological use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10196025T
Other languages
English (en)
Inventor
Pekka Heino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEINO, PEKKA, HELSINKI, FI
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of DE10196025T1 publication Critical patent/DE10196025T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DE10196025T 2000-04-06 2001-02-05 Dermatologische Verwendung und ein dermatologisches Präparat Withdrawn DE10196025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (1)

Publication Number Publication Date
DE10196025T1 true DE10196025T1 (de) 2003-03-13

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10196025T Withdrawn DE10196025T1 (de) 2000-04-06 2001-02-05 Dermatologische Verwendung und ein dermatologisches Präparat

Country Status (14)

Country Link
US (2) US20030144359A1 (de)
EP (1) EP1274416A1 (de)
JP (1) JP2003530349A (de)
AU (1) AU2001235506A1 (de)
CA (1) CA2405425A1 (de)
CH (1) CH695983A5 (de)
DE (1) DE10196025T1 (de)
DK (1) DK200201483A (de)
ES (1) ES2193003B1 (de)
FI (1) FI107018B (de)
GB (1) GB2377380B (de)
NO (1) NO20024810L (de)
SE (1) SE0202886L (de)
WO (1) WO2001076589A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1398024A3 (de) * 1995-06-07 2004-12-15 Karo Bio Ab Verwendung vom thyroidhormonen typ verbindungen
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
WO2005027895A2 (en) 2003-09-15 2005-03-31 Ordway Research Institute Thyroid hormone analogs and methods of use in angiogenesis
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US20100209382A1 (en) 2005-09-16 2010-08-19 Ordway Research Institute, Inc. Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
EP2120913B1 (de) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanopartikel- und polymerformulierungen für schilddrüsenhormonanaloga, -antagonisten und -formulierungen sowie verwendungen damit
US20100159021A1 (en) * 2008-12-23 2010-06-24 Paul Davis Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use
WO2010120506A1 (en) 2009-03-31 2010-10-21 Ordway Research Institute, Inc. Combination treatment of cancer with cetuximab and tetrac
EP2442800B1 (de) 2009-06-17 2019-04-24 NanoPharmaceuticals LLC Nanopartikel- und polymerformulierungen für schilddrüsenhormon, analoga, antagonisten sowie formulierungen und verwendung
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
WO2017214299A1 (en) 2016-06-07 2017-12-14 Nanopharmaceuticals, Llc NON-CLEAVABLE POLYMER CONJUGATED WITH αvβ3 INTEGRIN THYROID ANTAGONISTS
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
MX9603570A (es) * 1994-02-23 1997-03-29 Chiron Corp Metodo y composiciones para incrementar la vida media en suero de agentes farmacologicamente activos.
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
EP1398024A3 (de) * 1995-06-07 2004-12-15 Karo Bio Ab Verwendung vom thyroidhormonen typ verbindungen
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
DE60028957T2 (de) * 1999-04-26 2007-02-15 Danforth Jun., Elliot Pharmazeutische zusammensetzungen enthaltend tetrac sowie deren verwendungsverfahren
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
WO2001076589A1 (en) 2001-10-18
EP1274416A1 (de) 2003-01-15
ES2193003B1 (es) 2005-02-01
FI107018B (fi) 2001-05-31
GB0222880D0 (en) 2002-11-13
DK200201483A (da) 2002-10-03
NO20024810D0 (no) 2002-10-04
CH695983A5 (de) 2006-11-15
SE0202886D0 (sv) 2002-10-01
SE0202886L (sv) 2002-12-02
US20030144359A1 (en) 2003-07-31
GB2377380B (en) 2004-07-14
JP2003530349A (ja) 2003-10-14
ES2193003A1 (es) 2003-10-16
NO20024810L (no) 2002-12-06
GB2377380A (en) 2003-01-15
CA2405425A1 (en) 2001-10-18
AU2001235506A1 (en) 2001-10-23
FI20000818A0 (fi) 2000-04-06
US20050272817A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
DE60038200D1 (de) ren Herstellung und Verwendung
DE10196025T1 (de) Dermatologische Verwendung und ein dermatologisches Präparat
DE50112013D1 (de) Deodorantien und antiperspirantien
ATE298337T1 (de) Neue verwendung sowie neue n-azabicycloamid- verbindungen
DE60127551D1 (de) Silikonverbindung und kosmetische zubereitung
FR2799363B1 (fr) Implant medical a meandres en zigzag
DE60144260D1 (de) Wegwerfwindel
DE60106275T8 (de) Dermatologische zusammensetzung
DE60128470D1 (de) Haarpflegezubereitung
DE60120890D1 (de) Wegwerfwindel
DE50106399D1 (de) Chirurgisches element
DE60131102D1 (de) Monofilamentband
DE60124963D1 (de) Befestigungsmittel
DE60125492D1 (de) Wegwerfwindel
DE60119137D1 (de) Gleitelement und herstellungsverfahren dafür
ATE258035T1 (de) Wegwerfartikel für menschliche fäkalien
DE50106596D1 (de) Haftklebemasse und ihre verwendung
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE60105232D1 (de) Wegwerfwindel
DE60112000D1 (de) Handgelenktotalprothese
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE50105970D1 (de) Verstemmstempel und verwendung desselben
DE50103720D1 (de) Befestigungselement
AU4319001A (en) Microcompetiton and human disease
DE60114278D1 (de) Kalenderuhr

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: HEINO, PEKKA, HELSINKI, FI

8139 Disposal/non-payment of the annual fee